Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...

Mizuho lowered the firm’s price target on Vertiv (VRT) to $115 from $145 and keeps an Outperform rating on the shares. The firm reduced ...

Emkay Global maintained a 'BUY' rating with a target price of Rs 400 ... need to focus on growth for us to turn constructive on the stock." VRL Logistics is projected to see a 9% increase in ...

JPMorgan slashed its price targets on 25 companies in the internet ... and doing so within a shorter timeframe. There is an AI stock that went up since the beginning of 2025, while popular AI ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price ...

Investing.com -- Amid concerns over tariff risks, UBS has revised its stock price targets for Canadian rail companies CPKC and CN. This follows the announcement of U.S. reciprocal tariffs last ...

The stock, however, may not have much room to run, according to new research. Oppenheimer analysts in a Monday note cut their price target on the giant retailer's shares to $95 from $110 ...

A longtime Tesla bull has slashed his price target for the stock by 43% — arguing that President Trump’s trade war and Elon Musk’s controversial ties with the president have created a ...

Learn More » Ives, who formerly had the highest price target on Wall Street, lowered his expectations on Tesla's stock from $550 per share to $315, which still implies significant upside from ...

Evercore ISI adjusted its price target for Delta by 13%, from $80 to $70, while continuing to recommend the stock with an “outperform” rating. Last week, Jefferies analysts downgraded American ...

Even as the stock trended downward over the past few months, he maintained a highly bullish price target of $550 and maintained his optimism that TSLA would rebound. On April 6, that finally ...

Shares of Apple pulled back after Wedbush analysts slashed their price target on the stock, saying they're still bullish on Apple but believe it will be more badly damaged by President Trump's ...